ask="N/A"
ask_size="N/A"
average_daily_volume="78624"
bid="8.50"
bid_size="900"
book_value="-48.49"
change="-0.44"
change_from_200_day_moving_average="-1.37"
change_from_50_day_moving_average="-0.04"
change_from_52_week_high="-6.28"
change_From_52_week_low="1.33"
change_in_percent="-4.38%"
close="9.60"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-26.44"
ebitda="-16.46M"
eps_estimate_current_year="-4.66"
eps_estimate_next_quarter="-0.34"
eps_estimate_next_year="-1.80"
ex_dividend_date="N/A"
float_shares="7492000"
high="9.98"
high_52_weeks="15.88"
last_trade_date="2/2/2017"
last_trade_price="9.60"
last_trade_size="1791"
last_trade_time="4:00pm"
low="9.53"
low_52_weeks="8.27"
market_capitalization="161.01M"
moving_average_200_day="10.97"
moving_average_50_day="9.64"
name="Obalon Therapeutics
Inc."
notes="N/A"
one_year_target_price="19.00"
open="9.98"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-12.53%"
percent_change_from_50_day_moving_average="-0.41%"
percent_change_from_52_week_high="-39.55%"
percent_change_from_52_week_low="+16.08%"
previous_close="10.04"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="46.72"
revenue="3.60M"
shares_outstanding="16772000"
short_ratio="4.43"
stock_exchange="NGM"
symbol="OBLN"
volume="48381"
weeks_range_52="8.27 - 15.88"
